Zeno Corporation
Produces thermal-based over-the-counter health and beauty products for skin
About Zeno Corporation
Zeno Corporation, established in 2002, was a Houston-based medical device company that targeted the consumer dermatology market.
The firm focused on developing and commercializing a handheld, over-the-counter device designed for the thermal treatment of acne, positioning itself within the personal care and medical aesthetics sector. This product was intended for consumers seeking at-home solutions for common skin conditions.
Zeno Corporation successfully attracted significant investor interest, securing a total of $55 million in funding across five rounds. Its initial funding round occurred in May 2005. The investor roster included notable institutional firms such as L Catterton, Austin Ventures, and Sante Ventures. The company's final funding event was a Series C round on November 16, 2010, which raised $4 million.
Despite its early funding success and product development efforts, the company has since ceased operations and is now considered deadpooled.
Source: Dealroom company dataNews
Open roles
Zeno Corporation in the Houston ecosystem
The Zeno Corporation office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series B and later1 investor entered at this stage
L Catterton
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Zeno Corporation on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Zeno Corporation on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

